Therefore, our research aimed to investigate the involvement of LL22NC03 in HCC progression.<h4>Methods</h4>We analyzed the expression of IGF2BP3 in HCC specimens obtained from The Cancer Genome Atlas (TCGA) dataset. This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.